Table 2.
Demonstrates the impact of NBD on daily life (n = 294)
Items of the NBD questionnaire | N (%) | QoL score | |
---|---|---|---|
p-Value | OR (95% CI) | ||
Frequency of bowel movements | |||
Daily | 153 (52.0%) | 0.082 | |
2–6 times per week | 106 (36.1%) | ||
Less than once per week | 35 (11.9) | ||
Time used for each defecation | |||
Less than 30 min | 178 (60.6%) | < 0.001 | 1 |
31–60 min | 70 (23.8%) | 1.8 (1.3–3.4) | |
More than an hour | 46 (15.6%) | 2.3 (1.4–3.9) | |
Symptoms of headache, perspiration, or discomfort before or during defecation | |||
No | 127 (43.2%) | 0.021 | 1 |
Yes | 167 (56.8%) | 1.4 (1.2–3.5) | |
Taking medication (tablets) to treat constipation | |||
No | 243 (82.7%) | 0.091 | |
Yes | 51 (17.3%) | ||
Taking medication (drops or liquid) to treat constipation | |||
No | 145 (49.3%) | 0.018 | 1 |
Yes | 149 (50.7%) | 1.8 (1.6–2.7) | |
Frequency of digital stimulation | |||
Less than once per week | 112 (42.5%) | < 0.001 | 1 |
Once or more per week | 169 (57.5%) | 1.7 (0.9–2.6) | |
Frequency of involuntary defecation | |||
Daily | 43 (14.6%) | 0.103 | |
1–6 times a week | 111 (37.8%) | ||
3–4 times a month | 95 (32.3%) | ||
A few times a year or less | 45 (15.3%) | ||
Taking medication to treat fecal incontinence | |||
No | 242 (82.3%) | 0.24 | |
Yes | 52 (17.7%) | ||
Having experienced uncontrollable flatus | |||
No | 213 (72.4%) | 0.03 | |
Yes | 81 (27.6%) | ||
Having perianal skin problems | |||
No | 201 (68.4%) | 0.043 | |
Yes | 93 (31.6%) |
Bold numbers indicate significant results at p < 0.05
OR odds ratio, CI confidence interval